Literature DB >> 6634824

Aldehyde dehydrogenase in blood: a sensitive assay and inhibition by disulfiram.

O Tottmar, E Hellström.   

Abstract

The characteristics of human blood aldehyde dehydrogenase with indole-3-acetaldehyde as the substrate were investigated. Blood volumes of less than 25 microliter could be assayed. The Km-value was below 10 microM for indole-3-acetaldehyde and 100 microM for NAD+. The ALDH-activity appeared to be located exclusively in the intracellular fraction of the erythrocytes. Acetaldehyde or ethanol at concentrations up to 1 and 40 mM respectively did not affect the activity. Disulfiram caused a pronounced inhibition of the enzyme both in vitro and in vivo. The blood ALDH-activity in disulfiram-treated patients was not fully restored until 6 weeks after discontinuation of the treatment. The inhibition observed in vitro was reversed completely by 2-mercaptoethanol but only partially by glutathione. No restoration of activity in blood from disulfiram-treated patients was obtained with these two reagents. The inhibition found in vitro and in vivo was more pronounced when the assays were performed with indole-3-acetaldehyde than with acetaldehyde. The results suggest that different isozymes of ALDH are involved in the assay with these two substrates.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6634824     DOI: 10.1016/0091-3057(83)90154-5

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Inhibition of erythrocyte aldehyde dehydrogenase activity and elimination kinetics of diethyldithiocarbamic acid methyl ester and its monothio analogue after administration of single and repeated doses of disulfiram to man.

Authors:  B Johansson; Z Stankiewicz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice.

Authors:  Robert A Parise; Jan H Beumer; Dana M Clausen; Lora H Rigatti; Judy A Ziegler; Maura Gasparetto; Clayton A Smith; Julie L Eiseman
Journal:  Cancer Chemother Pharmacol       Date:  2013-09-24       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.